KIR/HLA genotypes predictive of missing KIR ligands are associated with improved outcome in patients with high-risk neuroblastoma treated with anti-GD2 monoclonal antibody therapy Meeting Abstract


Authors: Gallagher, M.; Tarek, N.; Zheng, J. T.; Venstrom, J. M.; Cheung, I. Y.; Modak, S.; Dupont, B.; Cheung, N. K. V.; Hsu, K. C.
Abstract Title: KIR/HLA genotypes predictive of missing KIR ligands are associated with improved outcome in patients with high-risk neuroblastoma treated with anti-GD2 monoclonal antibody therapy
Meeting Title: American Society of Pediatric Hematology/Oncology 24th Annual Meeting
Journal Title: Pediatric Blood and Cancer
Volume: 56
Issue: 6 Suppl.
Meeting Dates: 2011 Apr 13-16
Meeting Location: Baltimore, MD
ISSN: 1545-5009
Publisher: Wiley Periodicals, Inc  
Date Published: 2011-06-01
Start Page: 959
End Page: 960
Language: English
ACCESSION: WOS:000288463100225
PROVIDER: wos
DOI: 10.1002/pbc.23092
Notes: --- - Meeting Abstract - Poster 303 - SI - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Junting Zheng
    200 Zheng
  2. Nai-Kong Cheung
    648 Cheung
  3. Shakeel Modak
    249 Modak
  4. Nidale Tarek
    7 Tarek
  5. Katharine C Hsu
    184 Hsu
  6. Irene Y Cheung
    96 Cheung
  7. Bo Dupont
    264 Dupont